MAIA Biotechnology, Inc. earnings per share and revenue
On Nov 07, 2025, MAIA reported earnings of -0.27 USD per share (EPS) for Q3 25, missing the estimate of -0.19 USD, resulting in a -39.32% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -51.85% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were MAIA Biotechnology, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, MAIA Biotechnology, Inc. reported EPS of -$0.27, missing estimates by -39.32%, and revenue of $0.00, 0% as expectations.
How did the market react to MAIA Biotechnology, Inc.'s Q3 2025 earnings?
The stock price moved up 2.68%, changed from $1.12 before the earnings release to $1.15 the day after.
When is MAIA Biotechnology, Inc. expected to report next?
The next earning report is scheduled for Mar 19, 2026.
What are the forecasts for MAIA Biotechnology, Inc.'s next earnings report?
Based on 3
analysts, MAIA Biotechnology, Inc. is expected to report EPS of -$0.13 and revenue of -- for Q4 2025.